-
-
-
-
-
-
-
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives
-
-
-
-
-
-
-
After-hours movers: Astera Labs, Saratoga Investment, Kezar Life Sciences, and more
-
-
-
-
-
-
-
After-Hours Stock Movers 06/27: Morgan Stanley, Goldman Gain on Dividend Hike News Post Stress Tests (more...)
-
-
-
-
-
-
-
Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Kezar Life Sciences (KZR) Announces Proposed Common Share Offering
-
-
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

